Aclaris Therapeutics to Participate in Three November Healthcare Conferences
Rhea-AI Summary
Aclaris Therapeutics (NASDAQ: ACRS) will participate in three healthcare conferences in November 2025 with senior leadership presenting fireside chats.
Key events: Guggenheim on Nov 12, 2025 at 11:00 AM EST (Dr. Neal Walker et al.); Stifel on Nov 12, 2025 at 1:20 PM EST (Dr. Hugh Davis et al.); and Jefferies Global on Nov 17, 2025 at 2:00 PM GMT / 9:00 AM EST (Dr. Walker).
Live and archived webcasts will be available on the company Events page and accessible on the Aclaris website for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – ACRS
On the day this news was published, ACRS declined 2.09%, reflecting a moderate negative market reaction. Argus tracked a peak move of +9.5% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $6M from the company's valuation, bringing the market cap to $270M at that time.
Data tracked by StockTitan Argus on the day of publication.
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in three upcoming healthcare conferences in November.
- On Wednesday November 12, 2025, at 11:00 AM EST, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Guggenheim 2nd Annual Healthcare Conference in Boston, MA.
- On Wednesday November 12, 2025, at 1:20 PM EST, Aclaris’ President and Chief Operating Officer Dr. Hugh Davis and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Stifel 2025 Healthcare Conference in New York, NY.
- On Monday November 17, 2025, at 2:00 PM GMT (9:00 AM EST), Dr. Walker will participate in a fireside chat during the Jefferies Global Healthcare Conference in London, UK.
Live and archived webcasts of these events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
FAQ
When will Aclaris (ACRS) present at the Guggenheim Healthcare Conference in 2025?
What time is Aclaris (ACRS) scheduled at the Stifel 2025 Healthcare Conference?
When does Aclaris (ACRS) present at the Jefferies Global Healthcare Conference in London?
Where can investors watch Aclaris (ACRS) conference webcasts live or on demand?
How long will Aclaris (ACRS) keep the conference webcasts available online?
Who from Aclaris (ACRS) will participate in the November 12, 2025 fireside chats?
